Acquisition of Sanger Sequencing Services

The contract pertains to the acquisition of Sanger sequencing services for the Food and Drug Administration. It is identified as a forecast opportunity posted on March 11, 2026, under the NAICS code 518210, which relates to data processing and services. The specifics regarding solicitation number, set-aside status, and exact place of performance are not provided. Key contacts for the contract include a program point of contact reachable via cvmacquisitions@fda.hhs.gov designated as Cvm Acquisition Liaison, while the contracting officer has yet to be determined. The contract appears to support the FDA's operational needs in sequencing, critical for various research, regulatory, and analysis functions. Further details or updates are accessible through the provided industry opportunity forecast link.